Exciva
German company is a provider of targeted drug rescue program intended to involve pharmaceutical research and development.
Exciva has raised €60M across 2 funding rounds from 10 investors, most recently a Series B round in Jan 2026. Based in Heidelberg, Germany; active in Healthtech. Data as of 28 Oct 2026.
Heidelberg, Germanywww.exciva.com ↗
Total raised
€60M
€60,000,000
Funding rounds
2
Investors
10
distinct backers
Active since
2021-10
latest 2026-01
Funding by year
EUR raised per year · 2026 YTDExciva — funding by year — interactive chart.
Data table
| Exciva — funding by year | |
|---|---|
| 2021 | €9.0M |
| 2026 | €51M |
Signals
High confidenceRaise-next likelihood56
base rate 48% for Series B
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood20
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▲ 5y since founding (typical exit age)
- ▲ Recently backed by strong-exit-track investors
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-01-20 | Series B | €51M | Carma Fund,Andera Partners,EQT Life Sciences,Fountain Healthcare Partners,GIMV,LBBW Venture Capital GmbH+2 more | View deal → |
| 2021-10-26 | Series A | €9.0M | Andera Partners,Cure8,LBBW Venture Capital GmbH | View deal → |
Investors
10Related news
- Exciva Raises €9M in Series A Fundingfinsmes.com · 2021-10
- finsmes.com
Similar companies
same sector or country- Delivery Hero€7.1BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Helsing€2.9BGermany · AI
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
Global coverage: FundingData